These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35905001)

  • 1. Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy.
    Zorzi A; Mattesi G; Frigo AC; Leoni L; Bertaglia E; De Lazzari M; Cipriani A; Iliceto S; Corrado D; Migliore F
    J Cardiovasc Med (Hagerstown); 2022 Aug; 23(8):546-550. PubMed ID: 35905001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring.
    Galand V; Hwang E; Gandjbakhch E; Sebag F; Marijon E; Boveda S; Leclercq C; Defaye P; Rosier A; Martins RP
    Arch Cardiovasc Dis; 2021 May; 114(5):407-414. PubMed ID: 34088625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease.
    Guerra F; Malagoli A; Contadini D; Baiocco E; Menditto A; Bonelli P; Rossi L; Sticozzi C; Zanni A; Cai J; Maitra P; Villani GQ; Capucci A
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):1-9. PubMed ID: 30772229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic.
    Hauck C; Schober A; Schober A; Fredersdorf S; Hubauer U; Maier L; Keyser A; Huttelmaier M; Fischer T; Jungbauer C; Ücer E
    Eur J Med Res; 2022 Nov; 27(1):234. PubMed ID: 36348435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.
    O'Shea CJ; Thomas G; Middeldorp ME; Harper C; Elliott AD; Ray N; Lau DH; Campbell K; Sanders P
    Eur Heart J; 2021 Feb; 42(5):520-528. PubMed ID: 33321517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of ventricular arrhythmias related to COVID infection and vaccination in patients with Brugada syndrome: Insights from a large Italian multicenter registry based on continuous rhythm monitoring.
    Casella M; Conti S; Compagnucci P; Ribatti V; Narducci ML; Marcon L; Massara F; Valeri Y; De Francesco L; Martino AM; Ghiglieno C; Schiavone M; Balla C; Dell'Era G; Pelargonio G; Forleo GB; Iacopino S; Sgarito G; Calò L; Tondo C; Russo AD; Patti G
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1386-1394. PubMed ID: 37194742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018.
    Bennett MT; Brown ML; Koehler J; Lexcen DR; Cheng A; Cheung JW
    Heart Rhythm; 2022 Feb; 19(2):219-225. PubMed ID: 34656774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 lockdown on the arrhythmic burden of patients with implantable cardioverter-defibrillators.
    Sassone B; Virzì S; Bertini M; Pasanisi G; Manzoli L; Myers J; Grazzi G; Muser D
    Pacing Clin Electrophysiol; 2021 Jun; 44(6):1033-1038. PubMed ID: 34022067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results.
    Briongos-Figuero S; García-Alberola A; Rubio J; Segura JM; Rodríguez A; Peinado R; Alzueta J; Martínez-Ferrer JB; Viñolas X; Fernández de la Concha J; Anguera I; Martín M; Cerdá L; Pérez L;
    J Am Heart Assoc; 2021 Jan; 10(1):e018108. PubMed ID: 33356406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between ICD interventions and mortality is independent of their modality: clinical implications.
    Bencardino G; Di Monaco A; Rio T; Frontera A; Santangeli P; Leo M; Pelargonio G; Perna F; Narducci ML; Gabrielli F; Lanza GA; Bellocci F; Rebuzzi A; Crea F
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1363-7. PubMed ID: 25066621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.